An attempt to modulate the microporous diffusion of a model polypeptide by altering its secondary structure

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 10, Issue 2, 2003, Pages 65-72

  Johnston, Thomas P ^a   Salamat Miller, Nazila T ^a   Alur, Hemant H ^a   Mitra, Ashim K ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Aqueous Pore Diffusion; Conantokin G; Membrane Transport; Secondary Conformations

Indexed keywords

CALCIUM; CALCIUM ION; CONANTOKIN G; ENZYME; POLYPEPTIDE;

ALPHA HELIX; ARTICLE; CIRCULAR DICHROISM; DIFFUSION; DIFFUSION COEFFICIENT; ENDOCYTOSIS; ENZYME INACTIVATION; EQUILIBRIUM DIALYSIS; HYDRODYNAMICS; MEMBRANE; MEMBRANE PERMEABILITY; MOLECULAR MODEL; POROSITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TRANSPORT;

EID: 0038025877     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/713840357     Document Type: Article

References (38)

1. Acaturk, F., and Robinson, J. R. 1996. Vaginal permeability and enzymatic activity studies in normal and ovariectomized rabbits. Pharm. Res. 13:779-783.
2. Aungst, B. J., and Rogers, N. J. 1989. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm. 53:227-234.
3. Bai, J. P., and Amidon. G. L. 1992. Structural specificity of mucosal-cell transport and metabolism of peptide drugs: Implication for oral peptide drug delivery. Pharm. Res. 9:969-978.
4. Benes, L., Claustrat, B., Horriere, F., Geoffriau, M., Konsil, J., Parrott, K. A., DeGrande, G., McQuinn, R. L., and Ayres, J. W. 1997. Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: A crossover study with melatonin. J. Pharm. Sci. 86:1115-1119.
5. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E. 2000. The protein data bank. Nucleic Acids Res. 28:235-242.
6. Blandl, T., Zajicek, J., Prorok, M., and Castellino, F. J. 1997. Metal-ion binding properties of synthetic conantokin-G. Biochem. J. 328:777-783.
7. Chen, Y. H., Yans, Y., and Martinez, H. M. 1972. Determination of the secondary structures of proteins By CD and optical rotatory dispersion. Biochemistry 11:4120-4131.
8. Davidson, M. G., and Deen, W. M. 1988. Hindered diffusion of water-soluble macromolecules in membranes. Macromolecules 21:3474-3481.
9. Dooley, C. T., Chung, N. N., Wilkes, B.C., Schiller, P. W., Bidlack, J. M., Pasternak, G. W., and Houghten, R. A. 1994. An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library. Science 266:2019-2021.
10. Dowty, M. E., Knuth, K. E., Irons, B. K., and Robinson, J. R. 1992. Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro. Pharm. Res. 9:1113-1122.
11. Freedman, S. J., Blostein, M. D., Baleja, J. D., Jacobs, M., Furie, B. C., and Furie, B. 1996. Identification of the phospholipid binding in the vitamin K-dependent blood coagulation protein factor IX. J. Biol. Chem. 271:16227-16236.
12. Gangawar, S., Jois, S. D., Siahaan, T. J., Vander Velde, D. G., Stella, V. J., and Borchardt, R. T. 1996. The effect of conformation on membrane permeability of an acyloxyalkoxy-linked cyclic prodrug of a model hexapeptide. Pharm. Res. 13:1657-1662.
13. Gudmundsson, G. S., Jois, S. D., Vander Velde, D. G., Siahaan, T. J., Wang, B., and Borchardt, R. T. 1999. The effect of conformation on the membrane permeation of coumarinic acid- and phenylpropionic acid-based cyclic prodrugs of opioid peptides. J. Pept. Res. 53:383-392.
14. Guillot, G., Léger, L., and Rondelez, F. 1985. Diffusion of large flexible polymer chains through model porous membranes. Macromolecules 18:2531-2537.
15. Harris, A. S., Ohlin, M., Lethagen, S., and Nilsson, I. M. 1988. Effects of concentration and volume on nasal bioavailability and biological response to desmopressin. J. Pharm. Sci. 77:337-339.
16. He, Y.-L., Murby, S., Warhurst, G., Gifford, L., Walker, D., Ayrton, J., Eastmond, R., and Rowland, M. 1998. Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of poly(ethylene glycol) and D-Peptides. J. Pharm. Sci. 87:626-633.
17. Jasti, B. R., Zhou, S., Mehta, R. C., and Li, X. 2000. Permeability of antisense oligonucleotide through porcine buccal mucosa. Int. J. Pharm. 208:35-39.
18. Johnston, T. P., Rahman, A., Alur, H. H., Shah, D., and Mitra, A. K. 1997. Permeation of unfolded basic fibroblast growth factor (bFGF) across rabbit buccal mucosa - Does unfolding of bFGF enhance transport? Pharm. Res. 15:246-253.
19. Knipp, G. T., Ho, N. F. H., Barsuhn, C. L., and Borchardt, R. T. 1997. Paracellular diffusion in caco-2 cell monolayers: Effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. J. Pharm. Sci. 86:1105-1110.
20. Lee, V. H. L. 1991. Peptide and Protein Drug Delivery. New York: Marcel Dekker, 1-300.
21. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46:3-26.
22. Manning, M. C., Patel, K., and Borchardt, R. T. 1989. Stability of protein pharmaceuticals. Pharm. Res. 6:903-918.
23. Martin, A. 1993. Physical Pharmacy. Philadelphia: Lea & Febiger, 212-250.
24. Merrifield, R. B., Juvvadi, P., Andreu, D., Ubach, J., Boman, A., and Boman, H. G. 1995. Retro and retroenantio analogs of cecropin-melittin hybrids. Proc. Natl. Acad. Sci. USA 92:3449-3453.
25. Milstein, S. J., Leipold, H., Sarubbi, D., Leone-Bay, A., Mlynek, G. M., Robinson, J. R., Kasimova, M., and Freire, E. 1998. Partially unfolded proteins efficiently penetrate cell membranes: Implications for oral drug delivery. J. Cont. Rel. 53:259-267.
26. Pade, V., and Stavchansky, S. 1997. Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the caco-2 cell culture model. Pharm. Res. 14:1210-1215.
27. Pappenheimer, J. R., and Reiss, K. Z. 1987. Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat. J. Membr Biol. 100: 123-136.
28. Pappenheimer, J. R., Dahl, C. E., Karnovsky, M. L., and Maggio, J. E. 1994. Intestinal absorption and excretion of octapeptides composed of D-amino acids. Proc. Natl. Acad. Sci. USA 91:1942-1945.
29. Pappenheimer, J. R., Karnovsky, M. L., and Maggio, J. E. 1997. Absorption and excretion of undegradable peptides: Role of lipid solubility and net charge. J. Pharm. Exp. Ther 280:292-300.
30. Pauletti, G. M., Okumu, F. W., and Borchardt, R. T. 1997. Effect of size and charge on the passive diffusion of peptides across caco-2 cell monolayers via the paracellular pathway. Pharm. Res. 14:164-171.
31. Prorok, M., Warder, S. E., Blandl, T., and Castellino, F. J. 1996. Calcium binding properties of synthetic γ-carboxyglutamic acid containing marine snail "Sleeper" peptides, conantokin G and conantokin T. Biochemistry 35:16528-16534.
32. Rigby, A. C., Buleja, J. D., Furie, B. C., and Furie, B. 1997a. Three dimensional structure of a γ-carboxyglutamic acid-containing conantoxine, conantokin G, from the marine snail conus geographus: The metal-free conformer. Biochemistry 36:6906-6914.
33. Rigby, A. C., Baleja, J. D., Li, L., Pederison, L. G., Furie, B. C., and Furie, B. 1997b. Role of γ-carboxyglutamic acid in the calcium-induced structural transition of conantokin G, a conantoxin from the marine snail conus geographus. Biochemistry 36:15677-15684.
34. Sayani, A. P., and Chien, Y. W. 1996. Systemic delivery of peptides and proteins across absorptive mucosae. Crit. Rev. Ther. Drug Carrier Syst. 13:85-184.
35. Skjaerbeak, N., Nielson, K. J., Lewis, R. J., Alewood, P., and Crail, D. J. 1997. Determination of the solution structure of conantokin G and conantokin T by CD and NMR spectroscopy. J. Biol. Chem. 272:2291-2299.
36. Veuillez, F., Kalia, Y. N., Jacques, Y., Deshusses, J., and Buri, P. 2001. Factors and strategies for improving buccal absorption of peptides. Eur. J. Pharm. Biopharm. 51:93-109.
37. Watanabe, Y., Kiriyama, M., Ito, R., Kikychi, R., Mizufune, Y., Nomura, H., Miyazaki,M., and Matsumoto, M. 1996. Pharmacodynamics and pharmacokinetics of recombinant human granulocyte colony-stimulating factor (rhGCSF) after administration of a rectal dosage vehicle. Biol. Pharm. Bull. 19:1059-1063.
38. Yang, C. Y., Dantzig, A. H., and Pidgeon, C. 1999. Intestinal peptide transport systems and oral drug availability. Pharm. Res. 16:1331-1343.